← back to search

Xiangyang Zhang

Tsinghua University · CN
Area of research
Psychiatry and Mental health · Biological Psychiatry
Research interest
Research interests include Schizophrenia research and treatment, Tryptophan and brain disorders, Stress Responses and Cortisol, and Treatment of Major Depression.
h-index
58
citations
12,410
works
515
NIH funding
primary concept
email

Recent publications

Unraveling the prevalence and key influencers of metabolic syndrome in Drug-Naïve, first-episode major depressive disorder patients with psychotic symptoms: A decision tree modeling approach
Psychiatry Research 2025cited by 2position: lastdoi
Prevalence and Risk Factors of Subclinical Hypothyroidism in Young and Middle‐Aged Patients With First‐Episode Drug‐Naïve Major Depressive Disorder
Depression and Anxiety 2025cited by 1position: lastdoi
Screening for depression and anxiety in lung cancer patients: A <scp>real‐world</scp> study using <scp>GAD</scp>‐7 and <scp>HADS</scp>
Thoracic Cancer 2024cited by 12position: middledoi
Neurophysiological markers of disease severity and cognitive dysfunction in major depressive disorder: A TMS-EEG study
International Journal of Clinical and Health Psychology 2024cited by 8position: lastdoi
Genetic polymorphisms in the 5-HT and endocannabinoid systems moderate the association between childhood trauma and burnout in the general occupational population
Progress in Neuro-Psychopharmacology and Biological Psychiatry 2024cited by 3position: lastdoi
Prevalence, demographics, and clinical characteristics of suicide attempts in first episode drug-naïve schizophrenia patients with comorbid severe depression
International Journal of Psychiatry in Clinical Practice 2024cited by 2position: lastdoi
Association between thyroid dysfunction, metabolic disturbances, and clinical symptoms in first-episode, untreated Chinese patients with major depressive disorder: Undirected and Bayesian network analyses
Frontiers in Endocrinology 2023cited by 29position: lastdoi
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study
Blood Advances 2023cited by 25position: middledoi
Alexithymia in chronic schizophrenia and its mediating effect between cognitive deficits and negative symptoms
Schizophrenia Research 2023cited by 20position: lastdoi
Prevalence and clinical correlates of abnormal lipid metabolism in first-episode and drug-naïve patients with major depressive disorder with abnormal glucose metabolism
Scientific Reports 2023cited by 16position: lastdoi
Gender differences in the association between anxiety symptoms and thyroid hormones in young patients with first-episode and drug naïve major depressive disorder
Frontiers in Psychiatry 2023cited by 12position: lastdoi
Prevalence and clinical correlates of thyroid dysfunction in first-episode and drug-naïve major depressive disorder patients with metabolic syndrome
Journal of Affective Disorders 2023cited by 12position: lastdoi
Association of subclinical hypothyroidism with metabolic syndrome and its components among outpatients with first-episode drug-naïve major depressive disorder: a large-scale cross-sectional study
European Archives of Psychiatry and Clinical Neuroscience 2023cited by 11position: lastdoi
Association between thyroid autoimmunity and clinical characteristics in first-episode and drug-naive depressed patients with suicide attempts
General Hospital Psychiatry 2023cited by 9position: middledoi
Gender difference in association between clinical symptoms and alexithymia in chronic schizophrenia: A large sample study based on Chinese Han population
Journal of Affective Disorders 2023cited by 9position: lastdoi
Prevalence and clinical correlates of abnormal glucose metabolism in young, first- episode and medication-naïve outpatients with major depressive disorder
Psychiatry Research 2023cited by 8position: lastdoi
Thyroid dysfunction in young, first-episode and drug-naïve patients with major depressive disorder: prevalence and associated clinical factors
Frontiers in Psychiatry 2023cited by 7position: lastdoi
Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study
Journal of Translational Medicine 2023cited by 7position: lastdoi
Acute effect of twice‐daily 15 mA transcranial alternating current stimulation on treatment‐resistant depression: a case series study
General Psychiatry 2023cited by 6position: middledoi
Prevalence and correlates of dyslipidemia in first-episode and drug-naïve major depressive disorder patients with comorbid abnormal glucose metabolism: Sex differences
Frontiers in Psychiatry 2023cited by 6position: lastdoi
Prevalence and risk factors of suicide attempts in young, first-episode and drug-naïve Chinese Han outpatients with psychotic major depressive disorder
European Archives of Psychiatry and Clinical Neuroscience 2023cited by 4position: lastdoi
Prevalence and clinical profile of comorbid anxiety in young adult patients with first‐episode and drug‐naive major depressive disorder
Early Intervention in Psychiatry 2023cited by 2position: lastdoi
Association between thyroid function and comorbid anxiety in first-episode and drug naïve patients with major depressive disorder
European Archives of Psychiatry and Clinical Neuroscience 2022cited by 25position: lastdoi
Association of high BMI with subclinical hypothyroidism in young, first-episode and drug-naïve patients with major depressive disorder: a large-scale cross-sectional study
European Archives of Psychiatry and Clinical Neuroscience 2022cited by 13position: lastdoi
Association Between Hippocampal Subfields and Clinical Symptoms of First-Episode and Drug Naive Schizophrenia Patients During 12 Weeks of Risperidone Treatment
Neurotherapeutics 2022cited by 10position: lastdoi
Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial
Frontiers in Pharmacology 2022cited by 6position: lastdoi
Sexual dimorphism in the relationship between Forkhead-Box P2 and BMI with cognitive deficits in schizophrenia
Frontiers in Aging Neuroscience 2022cited by 6position: lastdoi
The association of clinical correlates, metabolic parameters, and thyroid hormones with suicide attempts in first-episode and drug-naïve patients with major depressive disorder comorbid with anxiety: a large-scale cross-sectional study
Translational Psychiatry 2021cited by 82position: lastdoi
The Effect of Tai Chi Chuan on Emotional Health: Potential Mechanisms and Prefrontal Cortex Hypothesis
Evidence-based Complementary and Alternative Medicine 2021cited by 45position: middledoi
The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia
Psychopharmacology 2021cited by 38position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Xiaoe Lang · Shanxi Medical University32 papers (2018–2025)Zezhi Li · Second Military Medical University9 papers (2019–2022)Yongjie Zhou · Huazhong University of Science and Technology7 papers (2019–2023)Hanjing Emily Wu · The University of Texas Health Science Center at Houston6 papers (2019–2022)Meihong Xiu · The University of Texas Health Science Center at Houston6 papers (2018–2023)Na Zhao · Hebei Medical University5 papers (2021–2025)Xiangdong Du · Shihezi University4 papers (2018–2020)Guangya Zhang · Xiamen University4 papers (2018–2020)Bo Cao · Beijing Institute of Technology4 papers (2018–2022)Fengchun Wu · The First Affiliated Hospital, Sun Yat-sen University4 papers (2019–2023)Yuejiao Ma · University Hospital Heidelberg4 papers (2019–2025)Xiaohong Wang · Johannes Gutenberg University Mainz3 papers (2021–2025)Qiufang Jia · Soochow University3 papers (2018–2020)Dongmei Wang · University of Illinois Chicago3 papers (2022–2024)Chuanyi Kang · Harbin Medical University3 papers (2022–2025)Huixia Zhou · Nanjing University of Chinese Medicine3 papers (2022–2024)Xi Wu · Hunan Normal University3 papers (2021–2021)Liying Yang · South China Agricultural University3 papers (2022–2025)Wanqiu Yang · China Pharmaceutical University3 papers (2019–2022)Xiao E Lang · Shanxi Medical University3 papers (2021–2023)